ConductScience.org, home

Paper34867367

Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma.

Manni L and 3 others. Front Pharmacol, 2021. Cited by 26 papers, by iCite.

Cite this record

ConductScience Library. Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma. Papers, record 34867367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34867367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Intranasal Delivery of Nerve Growth Factor in Neurodegenerative Diseases and Neurotrauma.
PubMed
Journal
Front Pharmacol
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
26
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2021-12-07
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Manni LLuigi
2Conti GGiorgio
3Chiaretti AAntonio
4Soligo MMarzia

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References142

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132547681Advances in treatment of neurodegenerative diseases: Perspectives for combination of stem cells with neurotrophic factors.World J Stem Cells2020https://conductscience.org/library/papers/32547681PubMed
228710024Intranasal nerve growth factor attenuating the seizure onset via p75R/Caspase pathway in the experimental epilepsy.Brain Res Bull2017https://conductscience.org/library/papers/28710024PubMed
324961518Neuroprotective role of nerve growth factor in hypoxic-ischemic brain injury.Brain Sci2013https://conductscience.org/library/papers/24961518PubMed
48548316Quantitative analysis of the olfactory pathway for drug delivery to the brain.Brain Res1995https://conductscience.org/library/papers/8548316PubMed
58025717Positive feedback between acetylcholine and the neurotrophins nerve growth factor and brain-derived neurotrophic factor in the rat hippocampus.Eur J Neurosci1994https://conductscience.org/library/papers/8025717PubMed
633358332Glucose metabolism: A link between traumatic brain injury and Alzheimer's disease.Chin J Traumatol2021https://conductscience.org/library/papers/33358332PubMed
722586589Intranasal insulin suppresses food intake via enhancement of brain energy levels in humans.Diabetes2012https://conductscience.org/library/papers/22586589PubMed
825676388Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.Alzheimers Dement2015https://conductscience.org/library/papers/25676388PubMed
921911655Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.Arch Neurol2012https://conductscience.org/library/papers/21911655PubMed
101540306Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).J Neural Transm Park Dis Dement Sect1992https://conductscience.org/library/papers/1540306PubMed
119701676Intracerebroventricular infusion of nerve growth factor in three patients with Alzheimer's disease.Dement Geriatr Cogn Disord1998https://conductscience.org/library/papers/9701676PubMed
1211735609Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.Clin Pharmacokinet2001https://conductscience.org/library/papers/11735609PubMed
1330081536Tailoring Formulations for Intranasal Nose-to-Brain Delivery: A Review on Architecture, Physico-Chemical Characteristics and Mucociliary Clearance of the Nasal Olfactory Mucosa.Pharmaceutics2018https://conductscience.org/library/papers/30081536PubMed
1411480588Effect of nerve growth factor on endothelial cell biology: proliferation and adherence molecule expression on human dermal microvascular endothelial cells.Arch Dermatol Res2001https://conductscience.org/library/papers/11480588PubMed
156136314NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal rat forebrain: evidence for a physiological role of NGF in the brain?Brain Res1983https://conductscience.org/library/papers/6136314PubMed
1629582053Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.JAMA Neurol2018https://conductscience.org/library/papers/29582053PubMed
1715852017A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease.Nat Med2005https://conductscience.org/library/papers/15852017PubMed
181849459The trk proto-oncogene encodes a receptor for nerve growth factor.Cell1991https://conductscience.org/library/papers/1849459PubMed
202411537Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation.EMBO J1985https://conductscience.org/library/papers/2411537PubMed
2133413694Loss of cholinergic innervation differentially affects eNOS-mediated blood flow, drainage of Aβ and cerebral amyloid angiopathy in the cortex and hippocampus of adult mice.Acta Neuropathol Commun2021https://conductscience.org/library/papers/33413694PubMed

See all 142 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.

PMIDTitleJournalYearIn PapersSource
42651149CHF6467 Exerts Neuroprotective Effects in the Rat Model of Acute Ischemic Stroke.Brain Sci2026https://conductscience.org/library/papers/42651149PubMed
42507332Disease mechanisms and translational barriers guide nanocarrier design for nose to brain delivery in Alzheimer's disease.Discov Nano2026https://conductscience.org/library/papers/42507332PubMed
42293152Application of neurodegenerative disease treatment strategies in tinnitus: mechanisms, translation, and prospects.Front Aging Neurosci2026https://conductscience.org/library/papers/42293152PubMed
42110196Toward an NGF-based therapy for Rett syndrome.Front Neurosci2026https://conductscience.org/library/papers/42110196PubMed
42075845Neurofunctional and Clinical Effects of Intranasal Human Recombinant Nerve Growth Factor in Children with Acquired Brain Injury.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42075845PubMed
41471293Nerve Growth Factor in Diabetes Mellitus: Pathophysiological Mechanisms, Biomarkers and Therapeutic Opportunities.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41471293PubMed
40730695Intranasal delivery route for neurodegenerative diseases: recent insights and future directions.Drug Deliv Transl Res2026https://conductscience.org/library/papers/40730695PubMed
40574087Intranasal Drug Delivery Technology in the Treatment of Central Nervous System Diseases: Challenges, Advances, and Future Research Directions.Pharmaceutics2025https://conductscience.org/library/papers/40574087PubMed
39901221Intranasal delivery of hMSC-derived supernatant for treatment of ischemic stroke by inhibiting the pro-inflammatory polarization of neutrophils.Stem Cell Res Ther2025https://conductscience.org/library/papers/39901221PubMed
39636503Filbertone-Induced Nrf2 Activation Ameliorates Neuronal Damage via Increasing BDNF Expression.Neurochem Res2024https://conductscience.org/library/papers/39636503PubMed
39598254Delivery of Neuroregenerative Proteins to the Brain for Treatments of Neurodegenerative Brain Diseases.Life (Basel)2024https://conductscience.org/library/papers/39598254PubMed
39455939Intranasal administration of recombinant human BDNF as a potential therapy for some primary headaches.J Headache Pain2024https://conductscience.org/library/papers/39455939PubMed
39300821Clinical-grade intranasal NGF fuels neurological and metabolic functions of Mecp2-deficient mice.Brain2025https://conductscience.org/library/papers/39300821PubMed
37789391Intranasal human-recombinant NGF administration improves outcome in children with post-traumatic unresponsive wakefulness syndrome.Biol Direct2023https://conductscience.org/library/papers/37789391PubMed
37770684Optic Pathway Gliomas: The Trends of Basic Research to Reduce the Impact of the Disease on Visual Function.Adv Tech Stand Neurosurg2023https://conductscience.org/library/papers/37770684PubMed
36204836Intranasal nerve growth factor for prevention and recovery of the outcomes of traumatic brain injury.Neural Regen Res2023https://conductscience.org/library/papers/36204836PubMed
35496270Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy.Front Pharmacol2022https://conductscience.org/library/papers/35496270PubMed

Download CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34867367

GET https://conductscience.org/api/papers/v1/34867367/references?page=2